Garrett M Brodeur

USPTO Granted Patents = 8 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Philadelphia, PA (US) (1997)
Wynnewood, PA (US) (2009 - 2023)

Company Filing History:

6 out of 281

The Children's Hospital of Philadelphia

Years Active: 1997-2025

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12311028 - Polymer-based macromolecular prodrugs (2025-05-27),

2. 11642414 - Polymer-based macromolecular prodrugs (2023-05-09),

3. 11633485 - Cleavable esters for nanocarrier-based cancer therapy (2023-04-25),

4. 11253603 - Polymer-based macromolecular prodrugs (2022-02-22),

5. 10357490 - Combinations for the treatment of neuroblastoma (2019-07-23),

6. 10085979 - Combinations for the treatment of neuroblastoma (2018-10-02),

7. 7553659 - CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof (2009-06-30),

8. 5601820 - Compositions and methods of making and using human full length TRK-B (1997-02-11),

Title: The Innovative Contributions of Garrett M Brodeur

Introduction

Garrett M Brodeur is a notable inventor based in Wynnewood, PA (US), recognized for his significant contributions to the field of medicine, particularly in cancer treatment. With a total of 8 patents to his name, Brodeur has made strides in developing innovative therapies that leverage macromolecular prodrugs.

Latest Patents

Among his latest patents, Brodeur has developed polymer-based macromolecular prodrugs. These innovative prodrugs involve camptothecin analogs that are covalently bonded to polymers through ester bonds, which are labile under physiological conditions. His work provides methods for treating cancer, especially neuroblastoma, using these macromolecular prodrugs.

Career Highlights

Throughout his career, Brodeur has worked with esteemed organizations such as The Children's Hospital of Philadelphia and Ignyta, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Michael Chorny and Ivan Alferiev. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.

Conclusion

Garrett M Brodeur's work exemplifies the impact of innovation in the medical field, particularly in the fight against cancer. His patents and collaborations highlight his commitment to improving patient outcomes through advanced therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.